Milestone Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,327
Closed -$210K – 277
2026
Q2
$210K Buy
+1,327
New +$179K 0.03% 255

Other funds holding XBI

Milestone Asset Management's XBI Position: Q3 2026 in Review

Milestone Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 1,327 shares — an estimated $210K sold.

Milestone Asset Management first reported a position in XBI in Q2 2026 and held it in 1 quarter. The position peaked at $210K in Q2 2026. 959 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Milestone Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
  • Milestone Asset Management sold 1,327 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $210K.
  • Milestone Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2026 and held it in 1 quarter.
  • Milestone Asset Management's State Street SPDR S&P Biotech ETF position peaked at $210K in Q2 2026.
  • 959 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Milestone Asset Management's 13F filing for Q3 2026, filed 15 Oct 2026.